CAS: 1095207-05-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Crenezumab REF: TM-T77152CAS: 1095207-05-8 | 95% - 95% | 275.00 €~2,493.00 € | Tue 07 Jan 25 |
 | Crenezumab REF: 3D-CLA1279CAS: 1095207-05-8 | - - - | To inquire | Wed 15 Jan 25 |
Crenezumab
CAS:1095207-05-8
Crenezumab (MABT 5102A) is a fully humanized anti-amyloid-beta antibody that binds to multiple forms of …
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T77152
| 1mg | 275.00 € | ||
| 5mg | 812.00 € | ||
| 10mg | 1,287.00 € | ||
| 25mg | 1,850.00 € | ||
| 50mg | 2,493.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Crenezumab
CAS:1095207-05-8
A fully humanized monoclonal antibody (from mouse) against human 1-42 β-amyloid (Aβ).
Ref: 3D-CLA1279
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
